Method of prophylaxis of acute renal failure
US5273961A · kind A · utility
50Cited by
2References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 22, 1992 |
| Grant date | Dec 28, 1993 |
| Priority date | — |
| Expiry date | Sep 22, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is disclosed for the prophylactic treatment of mammals at risk for acute renal failure, whether due to renal ischemia or nephrotoxic damage. This method involves administering to the mammal, before or at the time that the acute renal failure is expected to occur or is occurring, an effective amount of IGF-I. Preferably, the IGF-I is native-sequence, mature human IGF-I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.